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1. Introduction 
Endometriosis is a chronic disease in which endometrium-like lesions are located 
ectopically, frequently in the pelvic cavity but also in more distant regions. It has been 
estimated that 5 to 10% of fertile women are suffering from the disease, and in a 
population of women with dysmenorrhoea (painful periods), around 50% have 
endometriosis (Faquhar, 2007). The symptoms include chronic pelvic pain, 
dysmenorrhoea, dyspareunia (pain during intercourse), and subfertility. The pathogenesis 
of endometriosis is unclear. Endometriosis is hormonal-dependent and therefore mainly 
found in women in the fertile age, although rare cases have been found in men and 
postmenopausal women. The risk is increased seven- to nine-fold for women who have a 
close relative (mother and/or sister) with endometriosis, indicating some genetic 
involvement (Simpson et al., 1980). Endometriosis displays malignant-like features, such 
as invasiveness and metastasis, and DNA viruses might play a role in endometriosis, like 
human papillomavirus (HPV) is part of the pathogenesis of cervix cancer (zur Hausen, 
2009). Signs of inflammation are the key findings in endometriosis. From the above, some 
evidence points towards a possible involvement of the type I interferons (IFNs). This 
chapter will discuss whether DNA-viruses and the innate immune system might be 
involved in the pathogenesis of endometriosis. 
1.1 Immunology and inflammation in endometriosis 
Inflammation, characterized by activated lymphocytes, neutrophils, and macrophages, is a 
key feature of endometriosis tissue, associated with the overproduction of prostaglandins, 
metalloproteinases, cytokines, and chemokines (Bulun, 2009). It is debated whether the 
peritoneal inflammation is a consequence or a cause of endometriosis, or both. The immune 
system is involved in the pathogenesis of endometriosis on multiple levels, of which 
important features will be presented in this section.  
It is believed that defective immunosurveillance in women with endometriosis contributes 
to the attachment, persistence and progression of the endometriosis tissue (Kyama et al., 
2003; Osuga et al., 2011). Following retrograde menstruation, endometrial cells in the 
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peritoneal cavity should be cleared by the immune system, and a number of mechanisms 
contribute to the failure of this in endometriosis. These mechanisms are summarized in 
figure 1 and will be addressed here in the order of disease progression. 
1.1.1 Viable endometrial cells in the peritoneal cavity 
The persistent endometriosis-associated presence of viable peritoneal endometrial cells is 
partially ascribed to augmented retrograde menstruation, which can directly induce 
endometriosis, probably by overcoming the immune systems by simple outnumbering 
(Kyama et al., 2003). Endometrial cell clearance is presumably also reduced by altered 
phagocytotic properties of peritoneal macrophages. Moreover, decreased cytotoxicity 
towards autologous endometrial cells by decreased natural killer (NK) cell activity is 
thought to be an immune defect in endometriosis and is correlated with disease severity 
(Osuga et al., 2011). The tightly regulated balance between T helper cells type 1 (Th1) and 2 
(Th2) is altered towards higher Th2 activity in women with endometriosis. These cells 
secrete interleukin 4 (IL-4) and IL-10, which are speculated to reduce NK and T-cell 
cytotoxicity, and thus further reducing immune surveillance. 
The endometrial cells themselves also contribute to their own enhanced survival. The 
transcriptional expression of intercellular adhesion molecule 1 (ICAM-1) is up-regulated in 
endometriosis lesions, a fact that might contribute to early implantation of peritoneal 
endometriosis (Wu et al., 2004). The inflammatory cytokines interferon γ (IFNγ) and IL-1β 
induce ICAM-1 protein expression and the secretion of the soluble form of ICAM-1, which 
competitively inhibits ICAM-mediated cytotoxicity thus increasing survival. Furthermore, 
the peritoneal endometrial cells also have a decreased ability to undergo apoptosis. 
1.1.2 Endometrial-peritoneal adhesion 
The immune system is believed to assist the adhesion of the viable endometrial cells (figure 
1). Increased peritoneal infiltration of leukocytes, especially macrophages, and an increased 
proportion of activated macrophages, is found in endometriosis patients (Haider & Knöfler, 
2009). Peritoneal macrophage depletion has been shown to effectively inhibit the initiation 
and growth of endometriosis implants in rats (Haber et al., 2009), pointing towards a 
pathogenic effect of macrophages. This inflammation is associated with elevated levels of 
inflammatory cytokines, growth factors and chemokines. 
The pleiotropic pro-inflammatory cytokine tumor necrosis factor α (TNFα) is mainly 
produced by monocytes and macrophages and stimulates the secretion of the interleukins 
IL-1, IL-6 and IL-8 by endometriotic cells (Haider & Knöfler, 2009). TNFα can either promote 
cell regeneration (through the Nuclear Factor kB (NF-κB) pathway) or cell destruction (by 
initiating the caspase cascade), depending on its local concentration, expression pattern of 
receptors, and abundance of inhibitors. Macrophages in the peritoneal fluid from women 
with endometriosis secrete higher levels of TNFα than those from healthy women, and 
elevated peritoneal fluid levels of TNFα has been detected in women with endometriosis. 
The adherence of endometrial stromal cells to mesothelial cells is significantly increased by 
pretreatment of mesothelial cells with TNF-α in vitro, suggesting a role in facilitating pelvic 
adhesion. 
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Fig. 1. The role of the immune system in the development and maintenance of 
endometriosis. Following retrograde menstruation, multiple altered actions of the immune 
system influence step-wise disease progression. PF, peritoneal fluid; NK cells, natural killer 
cells; ICAM, Intercellular Adhesion Molecule; TNF, Tumour Necrosis Factor; IL, interleukin; 
MCP, Monocyte Chemotactic protein; RANTES, Regulated upon Activation, Normal T-cell 
Expressed and Secreted; TGF, Transforming Growth Factor; MMP, Matrix 
Metalloproteinase; TIMPs, Tissue Inhibitor of Matrix Metalloproteinases; VEGF, Vascular 
Endothelial Growth Factor; DC, dendritic cells. Simplified overview inspired by (Kyama et 
al., 2003). 
TNFα also stimulates the growth of both endometrial and endometriotic stromal cells from 
women with endometriosis, whereas it inhibits the growth of endometrial cells from healthy 
women (Haider & Knöfler, 2009). The peritoneal fluid level of TNFα is correlated with 
disease severity. In addition, anti-TNFα therapy effectively reduces endometriosis lesions in 
rats and baboons (Zulfikaroglu et al., 2010) revealing a potential future medical treatment 
for endometriosis. However, a placebo-controlled clinical trial of anti-TNFα treatment failed 
to demonstrate a significant decrease of pain associated with deep endometriosis (see 
Haider & Knöfler, 2009). 
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IL-1β and IL-6 are also a pro-inflammatory cytokine found elevated in the peritoneal fluid of 
women with endometriosis, and macrophages in the peritoneal fluid produce IL-1β in vitro 
in the absence of stimulants (Bondza et al., 2009). Both IL-1α and IL-1β as well as IL-6 are 
involved in the activation of T-lymphocytes and the differentiation of B-lymphocytes, 
thereby contributing to the increased peritoneal active immune state in endometriosis.  
In addition to these cytokines, a number of chemokines have been implicated in the 
pathogenesis of endometriosis, believed to contribute by recruiting and activating 
leukocytes to the inflammatory sites, thereby assisting the adhesion process. Yet another 
member of the interleukin family, namely the chemokine IL-8 (also named CXCL-8) has 
been implicated in endometriosis (Bondza et al., 2009). Macrophages in the peritoneal 
fluid from women with endometriosis secrete higher levels of IL-8 than those from 
healthy women, which stimulate the growth of endometrial and endometriotic stromal 
cells. Elevated levels of IL-8 were found in the peritoneal fluid of women with 
endometriosis, and concentrations correlated with the severity of the disease. IL-8 
stimulates the adhesion of endometrial stromal cells to fibronectin (see Kyama et al., 2003) 
and is therefore likely to contribute to the adhesion of endometrial cells in the pelvic 
cavity. 
Monocyte chemotactic protein-1 (MCP-1, also named CCL2) is one of the most potent 
chemokines in attracting monocytes. MCP-1 has been found elevated in both peritoneal 
fluid and serum from women with endometriosis, and in the endometrial glands the level 
varies according to disease stage (Bondza et al., 2009). Moreover, estrogen up-regulates IL-1-
induced MCP-1 expression, which may occur locally in the inflammatory site and contribute 
to peritoneal macrophage recruitment and activation. 
The chemokine RANTES (regulated upon activation, normal T cell expressed and secreted, 
also named CCL5) plays an important role in recruiting several types of lymphocytes into 
the endometrium (Fang et al., 2009). It is secreted by stromal cells at the endometriosis 
lesions upon stimulation with TNFα, IFNγ, or IL-1β. IL-1β treatment yields a higher level of 
RANTES in endometriotic compared with endometrial cells from endometriosis patients, 
which in turn display higher levels than normal endometrial cells, entailing increased 
monocyte chemotactic activity. This is presumed to be a major contributor to leukocyte 
recruitment and inflammation in the pathogenesis of endometriosis. 
It should be noted that the results on whether cytokines and chemokines are involved are 
equivocal. However, accumulating evidence predominantly reports that both cytokines and 
chemokines through enhanced local inflammation and cellular adhesion contribute to the 
pathogenesis of endometriosis. 
Transforming growth factor β (TGFβ) peritoneal fluid levels are significantly higher in 
women with endometriosis compared with healthy control women, and the TGFβ level 
increases with the severity of the disease (Liu et al., 2009). The adhesion of human 
endometrial cells to murine peritoneum is increased by treatment with TGFβ (as well as 
with IL-1β, IL-6, and TNFα) (Omwandho et al., 2009). The same could not be shown for 
human peritoneal mesothelial cells, but TGFβ enhances trans-mesothelial invasion by 
primary and immortalized endometrial epithelial cell lines in vitro (Liu et al., 2009).  
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1.1.3 Ectopic implantation and invasion 
TGF-β might not only facilitate adhesion but also implantation in endometriosis (figure 1). 
Its expression in the endometrium varies with the menstrual cycle, peaking at the time of 
menstruation (Omwandho et al., 2009). This expression pattern is roughly opposite to that of 
TNFα, and co-expression with progesterone occurs in the secretory phase (figure 2). TGFβ 
has been shown to mediate progesterone-associated suppression of matrix 
metalloproteinase (MMP) expression in endometrial tissue, and it is required for 
progesterone action in the prevention of experimental endometriosis (Bondza et al., 2009). 
 
Fig. 2. Levels of estrogen, progesterone, TGFβ, TNFα, and IFNα in the human endometrium 
during menstrual cycling. Numbers denote days after the first menstrual day. Dashed lines 
show levels following implantation. There are indications that TNFα and IFNα levels are 
up-regulated in early pregnancy. TGF, Transforming Growth Factor; TNF, Tumour Necrosis 
Factor; IFN, interferon. Schematic representation based on (Li et al., 2001; Haider & Knöfler, 
2009; Omwandho et al., 2009). 
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MMPs are important for the control of extracellular matrix turnover, and they are believed 
to influence the implantation of adhered endometriotic cells in endometriosis (Kyama et al., 
2003). The level of MMPs is in up-regulated and tissue inhibitors of matrix 
metalloproteinases (TIMPs) down-regulated in the peritoneal fluid from women with 
endometriosis compared with controls (Bondza et al., 2009). MMPs are upregulated in 
response to the inflammatory cytokines TNFα and IL-1 and are expressed during the 
proliferative and menstrual phases but suppressed by progesterone in the secretory phase. 
In the absence of a normal progesterone response of the endometriosis lesions, sensitivity to 
TGFβ may be altered, and this may result in a failure to down-regulate MMPs, thus 
contributing to the implantation failure.  
1.1.4 Growth and maintenance of endometriosis 
Following implantation, the growth and maintenance of endometriosis lesions is influenced 
by a number of factors (figure 1). First of all, the implanted tissue is in need of 
vascularization and an increase in the concentration of several angiogenic factors has been 
reported. IL-6 and IL-8, which as stated above are up-regulated in endometriosis, both 
promote angiogenesis (Bondza et al., 2009). IL-1β, which is also elevated in the peritoneal 
fluid of endometriosis patients, induces IL-6, the vascular endothelial growth factor (VEGF), 
and an angiogenic phenotype in endometriotic but not endometrial stromal cells. Women 
with moderate and severe endometriosis have elevated levels of both IL-6 and VEGF in the 
peritoneal fluid compared with healthy controls (Kyama et al., 2003), underlining that 
angiogenesis is a feature of disease exacerbation. Furthermore, high proliferative activity of 
endometriosis lesions is associated with increased levels of VEGF and its receptor as well as 
increased microvessel density (Bondza et al., 2009). 
A positive feedback of activated immune response contributes further to the maintenance of 
endometriosis. The reduced NK cell activity has been suggested to result in less effective 
killing of autologous dendritic cells (DCs) loaded with endometrial self-antigens. This 
would facilitate self-antigen presentation to autoreactive T cells and the subsequent 
production of autoantibodies (Kyama et al., 2003), pointing towards a pathogenic 
contribution by an autoimmune disease mechanism. Indeed, the frequency of 
autoantibodies towards endometrial antigens is elevated in both serum and peritoneal fluid 
of women with endometriosis compared with healthy women (Osuga et al., 2011). 
Activation of Th2 immune response in endometriosis and elevated B cell levels has been 
reported both systemically and locally in the endometriosis lesions, supposedly causing 
sustained autoantibody production and continuous infiltration of immune cells, thus 
maintaining the immunological contribution to the pathogenesis of endometriosis. 
2. Virus and endometriosis 
Pathogenic DNA virus infection has been associated with the aetiology of several human 
diseases. The double-stranded (ds) DNA viruses include herpesviruses, polyomaviruses, 
papillomaviruses, hepadnaviruses (e.g. hepatitis B virus (HBV)), adenoviruses and 
poxviruses. With the exception of poxviruses, these viruses often establish persistent or 
latent infections and can be reactivated in both healthy and immunosuppressed persons. 
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Only a few studies have addressed the possible involvement of a pathogenic virus in the 
aetiology of endometriosis (Oppelt et al., 2010; Vestergaard et al., 2010). The presence of 
specific human herpes viruses, human polyomaviruses, and human papillomaviruses was 
analysed. Also, the presence of human endogenous retroviruses have been investigated in 
endometriosis lesions (Hu et al., 2006; Oppelt et al., 2009), and these studies will be 
discussed in the following section.  
2.1 Herpes viruses 
The Herpesviridae are a large, diverse family of double-stranded, enveloped viruses. Eight 
human herpesviruses (HHVs) have been identified: Epstein-Barr virus (EBV, of the 
subfamily Gammaherpesvirinae), cytomegalovirus (CMV or HHV5 of the subfamily 
Betaherpesvirinae), herpes simplex virus type 1 and 2 (HSV-1 and HSV-2 of the subfamily 
Alphaherpesvirinae), varicella zoster (VZV), HHV6, HHV7, and the Karposi’s sarcoma 
herpes virus (KHSV or HHV8). The seroprevalence of each of these herpes viruses varies 
according to a number of demographic factors (Prober, 2011). For EBV, CMV, and HSV-1 
the prevalences range from 50 to 75%, whereas the prevalence for HSV-2 is about 25%. For 
VZV, HHV6 and HHV7 the seroprevalence is almost 100%, whereas the prevalence for 
HHV8 is less than 10%. The Herpesviridae family are found in many human tissue types, 
including the fallopian tubes (salpingitis) and the endometrium (see Vestergaard et al., 
2010). These viruses are commonly distributed as asymptomatic infectious agents but are 
also all associated with diseases, such as genital sores or a variety of malignancies. EBV 
can cause infectious mononucleosis and has been associated with lymphomas of B, T and 
NK cell origin, but also cancers of epithelial origin like nasopharyngeal carcinomas and 
gastric adenocarcinomas (Dolcetti & Masucci, 2003). EBV maintains latency in B cells. 
CMV can cause pneumonitis and delayed neurological complications like sensory neural 
hearing deficits and learning disabilities (Brown & Abernathy, 1998). CMV maintains 
latency in monocytes and macrophages. HSV-1 and HSV-2 can cause encephalitis and 
genital ulcerative disease (Wilson et al., 2009). The HSVs maintain latency in neuronal 
cells. VSV cause chickenpox (varicella) as primary infection following which it becomes 
latent in neuronal cells (Kennedy & Cohrs, 2010). VZV can be reactivated and thus cause 
herpes zoster (shingles) and extremely painful vesicular eruption. HHV6 cause roseola 
during the primary infection (Prober, 2011). HHV6 becomes latent in salivary glands, the 
brain and in mononuclear cells or macrophages. Most reactived HHV6 infections are 
asymptomatic.  
The presence of most of the herpes viruses in endometriosis has been analysed., 
Endometriosis samples from 32 patients were analysed for the presence of EBV, CMV, HSV-
1 and HSV-2 by multiplex PCRs (Vestergaard et al., 2010). None of the clinical samples were 
positive for any of these four herpes viruses. In another study, 66 endometriosis samples 
from 56 patients were tested for the presence of EBV, CMV, HSV-1, HSV-2, VZV, and HHV6 
by a PCR based analysis (Oppelt et al., 2010). Also this study failed to detect the presence of 
any of these six herpes viruses. Apart from HHV7 and HHV8, which has not yet been 
analysed, the six herpes viruses EBV, CMV, HSV-1, HSV-2, VZV, and HHV6 do not seem to 
be involved in the pathology of endometriosis.  
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2.2 Polyomaviruses 
The well-described human polyomaviruses of the Polyomaviridae family, JC (JCV), BK (BKV) 
and simian virus 40 (SV40) are widely distributed in the general population (Moens & 
Johannessen, 2008). Thus antibodies against JCV and BKV have been found in more than 
75% of the human adult population, and up to 15% of healthy humans are seropositive for 
SV40. These three polyomaviruses have been found in many different tissues (see 
Vestergaard et al., 2010). BKV has been found in the kidney tubule epithelium, urethral 
epithelium, the uterine cervix, and in the spleen. JCV has been found in tongue squamous 
cell epithelium, urethral epithelium, and in the spleen, whereas SV40 has been found in the 
liver and the mesothelium. Furthermore, these three polyomaviruses induce tumours in 
animal models and are able to transform cultured human cells (Moens & Johannessen, 2008). 
In 2007, two new human polyomaviruses, WU polyomavirus (WUV) and KI polyomavirus 
(KIV) were discovered in respiratory tract secretions and have subsequently been detected 
in faeces, blood, and lymphoid tissue (see Vestergaard et al., 2010). The full spectrum of 
their tissue tropism and their role in disease has yet to be elucidated. More recently, yet 
another human member of the Polyomaviridae family, the Merkel cell polyomavirus (MCV) 
was described in apparent association with Merkel cell carcinoma, an aggressive form of 
skin cancer (Moens & Johannessen, 2008). When analysed, none of these polyomaviruses 
were detected either in the endometrium or in endometriosis, suggesting an infrequent 
presence of polyomaviruses in the endometrium (Vestergaard et al., 2010).  
2.3 Human papillomaviruses 
Closely related to the polyomavirus family, the papillomavirus family is a very significant 
example of the large impact of a broad spectrum of pathogenic DNA viruses, which have 
emerged during the last two decades. More than 118 papillomaviruses have been fully 
described, and new virus types are constantly emerging (zur Hausen, 2009). The prevalence 
of human papillomavirus (HPV, of the family Papillomaviridae) in cervical carcinomas is 
99.7%. Specific high-risk HPV types have been shown to cause the vast majority of cervical 
cancers as well as a substantial proportion of other anogenital and head and neck cancers as 
well as certain cutaneous cancers. HPV has not yet been detected in intraperitoneal tissues, 
but HPV has been detected in blood, including on the surface of peripheral blood 
mononuclear cells, suggesting a potential alternative route of transmission (see Vestergaard 
et al., 2010). 
The prevalence of HPV in endometriosis has been analysed (Oppelt et al., 2010; Vestergaard 
et al., 2010). In one study, no HPV DNA was found in the endometriosis samples from 32 
patients (Vestergaard et al., 2010). In another study, certain high-risk HPV types was found 
in endometriosis lesions (Oppelt et al., 2010). However, due to previous cervical HPV 
infections in the analysed patients, it was concluded that the detected HPV in the 
endometriosis samples possibly originated from these associated malignant transformations 
and might not have any association with the endometriosis per se.  
In the endometrium, a HPV prevalence of less than 10% was found in samples from both 
women with endometriosis as well as controls, which is remarkably low compared with the 
well-known high frequencies of infection with these viruses (Vestergaard et al., 2010). It is 
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estimated that 75% to 80% of sexually active individuals are infected with HPV during their 
lifetime, with the highest rates in women younger than 25 years of age. However, as the 
mean age of the women enrolled in this particular study were between 32 and 36 years of 
age, most HPV infections would have been cleared by the immune system, correlating well 
with the fact that none of these women had genital HPV infection in their cervical smears at 
the time of analysis. However, it is possible that transient HPV infections could cause the 
initiation of malignant-like processes by a “hit-and-run” mechanism and in this way 
contribute to the initiation of endometriosis. This theory is yet to be investigated further.  
2.4 Endogenous retroviruses 
Retroviruses are RNA viruses, which integrate into the genome of the host cell in the form of 
a DNA copy, which is denominated the provirus. Endogenous retroviruses refer to 
proviruses integrated into germ line cells, which are transmitted from one generation to the 
next. Approximately 5% of the human genome consists of complete and partial sequences 
from human endogenous retroviruses (HERVs) (Muir et al., 2004). The significance and 
consequences of the presence of HERVs in the human genome have been the subject of 
intensive investigation. HERVs have been implicated in autoimmune diseases and neoplasia 
as well as in placental function and protection from exogenous retroviral infection. 
Considering the placental function, it is now believed that syncytin, a retroviral envelope 
protein encoded by the endogenous retrovirus HERV-W, is involved in the fusion of the 
cytotrophoblast cells to form the syncytial layer of the placenta, and the envelope protein 
encoded by ERV3 has been associated with cytotrophoblast differentiation. Other 
endogenous retroviruses like HERV-E also seem to be involved in placental function 
(reviewed in Muir et al., 2004).  
Expression of HERVs in endometriotic tissues has been detected, indicating that 
endogenous retrovirus expression might be involved in endometriosis (Hu et al., 2006; 
Oppelt et al., 2009). Endometriosis samples from 14 women were analysed for the presence 
of HERV-E HERV-W, HERV-I/T, and HERV-H mRNA by PCR analysis (Hu et al., 2006). It 
was found that HERV-E was expressed at higher levels in the endometriosis samples than in 
normal endometrium control samples. In another study, 15 endometriosis samples showed 
low levels of RNA encoding the HERV-W encoded envelope protein syncytin, as analysed 
by reverse transcriptase PCR (Oppelt et al., 2009). It was also found in this study that the 
endometriosis samples did not show an elevated expression of the HERV-W encoded 
envelope protein syncytin. Interestingly though, samples from the endometrium of women 
with endometriosis showed an increased expression of syncytin RNA compared with 
endometrial samples from controls, suggesting that this protein might be involved in the 
pathology of endometriosis. At this point, the involvement of endogenous virus expression 
in the pathology of endometriosis is not clarified. Further studies are required, analysing 
larger groups of endometriosis samples and including tissue samples from the 
endometrium of women with and without endometriosis.  
3. Type I interferon and endometriosis 
We will now focus on the putative implication of the important immune modulating 
cytokine family type I interferons in endometriosis, as a line of circumstantial evidence 
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indicates that these cytokines could be involved. A key constituent of the immune system 
that has been only slightly investigated in relation to endometriosis is the family of 
interferons (IFNs). IFNs are cytokines secreted from cells in response to viral challenge and 
various other stimuli. The human interferons are by structural homology classified into type 
I, which consists of IFNα (counting 13 subtypes), IFNβ, IFNε, IFNκ, and IFNω, type II, 
which is only IFNγ, and type III, the more recently discovered IFNλ (comprising 3 subtypes) 
(Platanias, 2005; Hall & Rosen, 2010). Secreted IFNs bind to specific plasma membrane 
receptors, which initiate intracellular pathways leading to the transcription of hundreds of 
interferon stimulated genes (ISGs) (Platanias, 2005; Hall & Rosen, 2010). In spite of their 
common signaling pathway, IFNα and IFNβ display specific activity profiles. 
Main biological activities resulting from IFN signaling are primarily antiviral but also anti-
proliferative, anti-angiogenic, and antigen-presenting effects as well as regulation of pro- 
and anti-apoptotic genes and proteins (Platanias, 2005). The current state of the cells and 
complex balances of feedback mechanisms determine the overall outcome of the IFN 
response, e.g. survival vs. apoptosis. Recombinant human IFNs (mainly IFNα and IFNβ) are 
used as therapeutic agents against a variety of cancers, multiple sclerosis, and viral diseases, 
such as hepatitis B and C.  
Type II IFN is produced only by activated T or NK cells and its primary role is to modulate 
the adaptive immune response, e.g. by contributing to the activation of macrophages and T 
cell development (Hall & Rosen, 2010). Expression of the receptors of type III IFN is 
primarily limited to epithelial and DCs, thus restricting their scope of action. We will only 
focus on type I IFNs and their possible role in endometriosis.  
High levels of type I IFNs are secreted rapidly by most cell types upon stimuli (Hall & 
Rosen, 2010). Type 1 IFNs have immunostimulatory effects on NK cells, macrophages and 
DCs, which all are essential effector cells in the innate immune system. Among the 
downstream targets of type I IFN signaling are the IFNs themselves as well as associated 
receptors, signal transducers and transcription factors enabling a strong feed-forward 
mechanism. It is strongly believed that type I IFNs are directly involved in the pathogenesis 
of autoimmune disease by enhancing the self-amplification of systemic autoimmunity (Hall 
& Rosen, 2010). The aberrant antigen-presentation of debris from apoptotic cells and the 
resulting production of autoantibodies in endometriosis could be speculated to give rise to a 
type I IFN-amplified autoimmune pathogenic mechanism. In autoimmunity, self antigens 
elicit an immune response that includes substantial production of type I IFNs. Upon DC 
presentation of endometrial autoantigens, type I IFN may then promote monocyte 
differentiation, DC survival and cytotoxic T cell activity, which may enhance killing of 
endometrial cells presenting autoantigens. Debris from dying cells is then taken up by DCs 
and presented for recognition by T cells in a self-amplifying loop. Type I IFNs also induce 
the differentiation of B cells, which would promote autoantibody production. Immune 
complexes of endometrial self antigens and autoantibodies would further amplify the IFN 
production, constituting yet another positive feedback loop. 
The approved drug Intron A (human recombinant IFNα-2b) has been proposed as a possible 
immunomodulatory therapeutic against reoccurrence of endometriosis cysts after surgery. 
The hypothesis was that this could enhance the cytotoxic activity of macrophages and 
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natural killer cells and thus reduce the growth of endometriosis tissue (Acién et al., 2002). 
Rats with surgically induced endometriosis showed persistent significant reductions in the 
implant sizes upon intraperitoneal or subcutaneous administration of human IFNǂ-2b. 
However, a clinical study showed that intraperitoneal administration of IFNα-2b following 
surgical treatment for endometriosis increased the cyst reoccurrence rate significantly after 
21 months. Hence, the normal anti-proliferative effects of type I IFNs appear to be 
challenged in endometriosis.  
The endometrial level of IFNǂ mRNA is increased in the mid-secretory phase of the human 
menstrual cycle (Li et al., 2001), which is the putative window of implantation (figure 2). It 
has been found that the transcription of IFNǂ and the interferon ǂ receptor 2 (IFNAR2) is 
highly up-regulated in the endometrium of women suffering from endometriosis compared 
with healthy women (Kao et al., 2003). Moreover, JAK1, which has an important function in 
type I IFN signaling, is up-regulated in endometriosis stromal cells compared with the 
endometrial cells from endometriosis patients (Matsuzaki et al., 2006). The sum of these 
findings suggests a role of type I IFN in the human endometrium and a possible 
dysregulation in endometriosis.  
The possible involvement of type I IFNs in endometriosis has recently been investigated 
directly (Vestergaard et al., 2011). A type I interferon-specific PCR Array indicated 
significantly down-regulated transcription of the genes HOXB2 and ISG20 in 
endometriosis lesions compared with endometrium from endometriosis patients and 
healthy controls, but no difference in the expression of any other interferon stimulated 
genes were observed. These results were independent of the menstrual phase. As only 
two out of 84 genes of the type I IFN response was significantly dysregulated in 
endometriosis, the type I IFNs do not appear to be generally involved in the pathogenesis 
of endometriosis. Yet, specific gene regulation involving type I IFNs could still play 
distinct roles in endometriosis. The putative involvement of ISG20, HOXB2 and HOXA10 
in the pathogenesis will now be discussed. 
3.1 The ISG20 protein 
The transcriptional expression of ISG20 (interferon-stimulated gene product of 20 kDa, also 
called HEM45) was shown by validated qRT-PCR to be highly down-regulated in 
endometriosis lesions (Vestergaard et al., 2011). ISG20 transcription is induced 
synergistically by type I and II IFNs, induced by estrogen, and regulated in a progesterone-
dependent manner in mice, especially in the mouse endometrium. This gene encodes a 3′ to 
5′ exonuclease with specificity for single-stranded RNA (and to a lesser extent for DNA), 
which is localized in the nucleus and is associated with promyelocytic leukemia (PML) 
protein nuclear bodies. The exonuclease has been proposed to down-regulate the estrogen-
dependent transcriptional response by degrading estrogen-induced mRNAs within PML 
oncogenic domains (PODs). The subcellular localization of ISG20 in the nucleus argues for 
its involvement in the maturation rather than in the degradation of mRNAs. 
ISG20 has also been implicated in the anti-angiogenic properties of interferon (Taylor et al., 
2008). In an in vitro angiogenic assay system, ISG20 was found to be up-regulated in 
endothelial cells treated with interferon, however, overexpression of ISG20 did not lead to 
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reduced angiogenesis per se. However, overexpression of the enzymatically inactive, 
dominant-negative ISG20 mutant inhibited angiogenesis in this system and potentiated the 
anti-angiogenic properties of interferon. How ISG20 might be involved in angiogenesis is 
currently not clear. 
The ISG20 protein mediates antiviral effects of interferons by inhibiting the replication of 
several RNA viruses, like vesicular stomatitis virus, influenza virus, encephalomyocarditis 
virus, West Nile virus, Dengue virus, hepatitis A and C viruses, yellow fever virus, and 
bovine viral diarrhea virus (Zhou et al., 2011). The antiviral activity of ISG20 is only 
observed with enzymatically active ISG20 expression, since expression of an ISG20 mutant 
without enzymatic activity, did not possess the same antiviral activities.  
Importantly, ISG20 mRNA was found to be up-regulated in the uterine epithelium during 
the implantation window in mouse (Pan et al., 2006). Whether abolished ISG20 enzyme 
activity is implicated in the pathogenesis of endometriosis or a marker of altered hormonal 
expression, or both, needs to be further investigated. 
3.2 The HOX proteins 
The HOX proteins encoded by the homeobox genes are DNA binding transcription factors 
known to regulate embryonic development. In addition, the HOX genes are dynamically 
expressed in the endometrium during the menstrual cycle, where they are necessary for 
endometrial growth, differentiation, and implantation (Cakmak & Taylor, 2010; Zanatta et 
al., 2010). Furthermore, HOX proteins are molecular mediators of the steroid hormones 
during endometrial cell development. 
It has been suggested that a HOX gene-related defect in endometrial development exists in 
patients with endometriosis (Zanatta et al., 2010). According to this theory, endometriosis 
might originate from estrogen stimulated metaplasia of mesenchymal embryonic cells 
distributed in the pelvis during organogenesis. However, transcriptional dysregulation of 
the HOX genes in the adult endometrium compatible with the more well-supported 
retrograde menstruation pathogenesis model is also well substantiated. Recently, a 
systematic dysregulation of HOX genes in the endometrium from healthy women compared 
with the endometrium in women with endometriosis has been demonstrated (Borghese et 
al., 2008). A down-regulation of HOXA and HOXB genes and an up-regulation of HOXC 
genes were found in endometrium from women with endometriosis compared with 
endometrium from healthy women. 
The HOXA10 protein is up-regulated in response to circulating estrogen and progesterone 
in the healthy endometrium, thus indicating a role in endometrial maturation, implantation 
and maintenance of pregnancy implantation (Cakmak & Taylor, 2010; Zanatta et al., 2010). 
HOXA10 transcription is normally up-regulated in the endometrium during the window of 
implantation but this up-regulation is abolished in women with endometriosis. Low levels 
of HOXA10 could explain the lower fertility of women with endometriosis, and this is 
further supported by studies of the HOXA10 knock-out mice, in which the targeted 
disruption of the HOXA10 gene generated uterine factor infertility. Also in the 
endometriotic tissue, the HOXA10 transcriptional levels were found to be low 
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(Langendonckt et al., 2010). The endometrial down-regulation of HOXA10 protein in 
women with endometriosis seems to be due to increased methylation of the HOXA10 
genomic enhancer region in the endometrium leading to epigenetic silencing of this gene 
(reviewed in Cakmak & Taylor, 2010). In conclusion, low levels of HOXA10 may result in 
resistance to progesterone action in the endometriotic tissue.  
HOXB2 is part of the HOX gene family involved mainly in embryonic development. A very 
solid down-regulation of HOXB2 in endometriotic lesions compared with endometrium 
from both endometriosis and healthy women has been observed (Vestergaard et al., 2011). 
Little is known about HOXB2 expression in the endometrium, but several studies have 
demonstrated that HOXB2 expression is altered in tumours. In a xenograft breast tumour 
mouse model, HOXB2 acts as a negative tumour growth regulator, since HOXB2 expression 
decreases proliferation of tumour cells (Boimel et al., 2011). Other results have shown that 
overexpression of HOXB2 in pancreatic, lung and cervical cancer was associated with 
malignancy. However, a more in-depth analysis correlated lower HOXB2 expression with 
higher grades of tumours. Finally, it has been reported that the HOXB2 protein binds the 
interferon-induced protein p205, involved in the growth inhibitory activities of interferon 
(see Vestergaard et al., 2011). Whether HOXB2 interaction with p205 modifies the growth 
inhibitory activities of p205 has not yet been investigated. Further studies are needed to 
determine the mechanism and implications of the abolished HOXB2 expression in 
endometriosis lesions.  
4. Conclusion 
The pathogenesis and the similarity to cancer invasiveness suggested that a viral 
background could be part of the pathogenesis of endometriosis, but so far no investigations 
have demonstrated this connection in the aetiology. The prevalence of pathogenic dsDNA 
viruses in the human endometrium was found to be generally low (0-10%), and nothing 
points towards any evidence that endometriosis is caused by currently known DNA viruses 
(Oppelt et al., 2010; Vestergaard et al., 2010). It can be speculated that the endometrium and 
endometriotic tissue is difficult to access or simply an unfavorable environment for virus 
progression, leading to a generally low prevalence in these deeper tissues. It is possible that 
viruses can infect the endometrium transiently but subsequently be either shed with the 
endometrial tissue during menstruation or be rapidly cleared by an efficient immune 
response. Thus stable infections of the endometrium would not be frequent. However, a 
pathogenic virus could theoretically initiate a malignant cell process during a shorter 
infectious period and then flee the scene. This “hit-and-run” strategy has been previously 
shown e.g. for CMV in vitro and indicated in clinical studies of both polyomaviruses and 
papillomaviruses (see Vestergaard et al., 2010). This could explain why no virus DNA so far 
has been found associated with endometriosis lesions. 
To address the viral “hit-and-run” strategy hypothesis, one could analyse for an elevated 
level of serum antibodies against the viruses, which would then show previous viral 
infections. Even though a broad selection of the most common pathogenic DNA viruses 
have been tested for, other more rare or even undiscovered viruses or bacteria might still 
be involved. Conclusively, the prevalence of pathogenic DNA viruses in the endometrium 
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and endometriosis lesions is very low and does not indicate a virological cause of 
endometriosis. However, the existence of a causative infectious agent can still not be ruled 
out at this point.  
The altered expression of a large number of genes has been reported in endometriosis (Kao 
et al., 2003; Matsuzaki et al., 2006), an imbalance mediated by altered levels of a number of 
signaling molecules as well as by epigenetic alterations. Dysregulation of a large number of 
hormones, cytokines, chemokines, and growth factors is a feature of endometriosis. The 
abolished expression of HOXA10, HOXB2 and ISG20 in the endometriosis tissue seems to be 
influenced by a number of these factors, which regulate gene transcription via complex, 
overlapping mechanisms, possibly in combination with the action of estrogen and 
progesterone. The observed abolishment of ISG20 and HOXB2 expression in endometriosis 
lesions indicates that they fail to be induced by estrogen. The altered ERα/ERβ ratio in 
endometriosis could be important in this mechanism. The lack of HOXA10 expression in the 
endometrium as well as in endometriotic lesions is probably due to epigenetic changes in 
the gene promoter, resulting in abolished response to estrogen and progesterone. Moreover, 
the expression of other HOX genes in endometriosis might shed a light on the function of 
this family of proteins in the development of this disease. 
As the aetiology of endometriosis is unknown, and as several factors are thought to 
influence the course of the disease, the pathogenesis of endometriosis is still a challenge. 
One of the main problems is the lack of a non-invasive test to diagnose endometriosis. 
Several markers have been investigated. The best known is CA125, which is not specific to 
endometriosis but frequently also elevated in cancer. CA125 is often elevated in 
endometriosis, and the level is to some extend related to the degree of the infiltration in 
active endometriosis. However, the CA125 levels are individual, and change in intensity 
of pain or other symptoms related to endometriosis are not automatically reflected in the 
level. Therefore, the identification of a non-invasive marker able to diagnose 
endometriosis would be of great importance. Furthermore, if this marker could indicate 
changes in disease intensity this would be a great help both for the patient and the doctor. 
The success of different treatments could also be measured more objectively e.g. by an 
independent marker. So far hormonal treatment is the first line of treatment, and if pain 
cannot be resolved by medication, surgery may be performed. However, the 
endometriosis often reoccurs and more operations are needed, thus bringing the risk of 
complications. 
As clarified in this chapter, many possibilities for causative or aetiological mechanism for 
the pathogenesis of endometriosis are in focus. If the aetiology of endometriosis is to be 
found related to virus, we can probably in the future prevent the disease or at least weaken 
the intensity. A marker for the disease based on virus aetiology would most likely be 
possible to develop, and the development of a specific treatment could be feasible. If HOX 
genes and/or ISG20 are involved in the aetiology of endometriosis, this would also give 
possibilities for new diagnostic tools and medical treatments. 
In conclusion, the possible involvement of viruses, type I IFNs, and the innate immune 
system in the pathogenesis of endometriosis is yet unclear. More investigations are needed 
in order to resolve the riddle of endometriosis. 
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